For applications such as sutures and artificial dura mater reinforcement! Polyglycolic acid has a wide range of potential uses.
Polyglutamic acid (PGA) is obtained by using glycolide (the cyclic dimer of glycolic acid) as a monomer and performing ring-opening polymerization. Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a variety of shapes, and is used in a wide range of applications in the medical field. Its excellent biocompatibility, biodegradability, and flexible processing characteristics make it an ideal innovative solution to contribute to the improvement of patients' quality of life (QOL). 【Features】 ■ Can be used as an artificial dura mater reinforcement material, etc. ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: crystalline, poorly soluble (excluding low molecular weight variants) *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Example)】 Test Items: Standards ■ Polymer Identification: Must match the IR spectrum of standard PGA ■ Melting Point (Tm): Tm = 223 − 235 (℃) ■ Melting Behavior: Tmax = 230 − 240 (℃) ■ MFR: MFR(240, 10) = 3.0 − 9.0 (g/10min) ■ Particle Size: Must not pass through a sieve with an opening of 500 µm * These are the specifications (standards) for our representative PGA polymer. * For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Uses】 ■Thread (single thread, knitted cord, mesh): Sutures, stents, artificial dura mater reinforcement materials, adhesion prevention membrane reinforcement materials, scaffolds, adhesion prevention membranes *For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Kyoto University Institute for Advanced Medical Research. Focusing on the field of medical polymers (macromolecules), we are engaged in two promising growth businesses: the "BioDegmer" business and the new products business, as well as research and development aimed at providing innovative solutions in the medical field. Under the management philosophy of "contributing to the health of people around the world by working on the development of better biomaterial products and providing innovative solutions in the medical field," we support the improvement of technologies in the next generation of regenerative medicine and the healthy well-being of people in three areas.